Osteopenia

Showing 1 - 25 of 167

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes, Osteopenia Trial in Odense (oral Semaglutide/Rybelsus, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Osteopenia
  • oral Semaglutide/Rybelsus
  • Placebo
  • Odense, Denmark
    Odense University Hospital
Sep 21, 2023

Calcium, Osteopenia, Bone Mineral Density Trial in Taipei (amorphous calcium carbonate/ Placebo)

Completed
  • Calcium
  • +3 more
  • amorphous calcium carbonate/ Placebo
  • Taipei, Taiwan
    Taipei Medical University
Apr 11, 2023

Breast Cancer, Osteopenia Trial in Valencia (bone densitometry)

Recruiting
  • Breast Cancer
  • Osteopenia
  • bone densitometry
  • Valencia, Spain
    Hospital Clínico Universitario de Valencia
Mar 9, 2023

Osteoporosis, Osteopenia, Bone Density, Low Trial in Huddinge (OsteoStrong, Individually Adapted and Combined Physical Training)

Active, not recruiting
  • Osteoporosis
  • +3 more
  • OsteoStrong
  • Individually Adapted and Combined Physical Training
  • Huddinge, Stockholms Län, Sweden
    Karolinska Institutet - Department of Neurobiology, Care Science
Jan 31, 2023

Chronic Health Conditions in Down Syndrome-Associated Acute

Not yet recruiting
  • Down Syndrome
  • +7 more
  • Neurological Assessments
  • +3 more
  • (no location specified)
Jan 18, 2023

Osteoporosis, Spine Fusion, Denosumab Allergy Trial in Shenzhen (Denosumab, Placebo)

Completed
  • Osteopenia
  • +2 more
  • Shenzhen, Guangdong, China
    ShenzhenPH
Jan 15, 2023

Osteoporosis, Osteopenia, Osteoporotic Fracture Trial in Durham, Salt Lake City, Richmond (Bone Health Service Model)

Recruiting
  • Osteoporosis
  • +2 more
  • Bone Health Service Model
  • Durham, North Carolina
  • +2 more
Jan 10, 2023

Osteopenia, Lumbar Spondylolisthesis Trial in Shenzhen (Denosumab 60 MG/ML, Zoledronate)

Recruiting
  • Osteopenia
  • Lumbar Spondylolisthesis
  • Shenzhen, Guangdong, China
    ShenzhenPH
Dec 29, 2022

Sickle Cell Disease, Osteoporosis, Osteopenia Trial in Orléans (Oral Nutritional Supplement)

Recruiting
  • Sickle Cell Disease
  • +2 more
  • Oral Nutritional Supplement
  • Orléans, France
    CHR Orléans
Dec 27, 2022

Osteopenia, Osteoporosis Trial in Minneapolis, Seattle (Pamidronate, Calcium and vitamin D)

Completed
  • Osteopenia
  • Osteoporosis
  • Minneapolis, Minnesota
  • +1 more
Dec 8, 2022

Osteopenia, Osteoporosis, Postmenopausal Osteoporosis Trial in Birmingham (Exercise training)

Not yet recruiting
  • Osteopenia
  • +3 more
  • Exercise training
  • Birmingham, Alabama
    University of Alabama at Birmingham
Nov 16, 2022

Bone Pain in Adults With Sickle Cell Disease

Recruiting
  • Sickle Cell Disease
  • +10 more
    • Sacramento, California
      UC Davis Comprehensive Cancer Center
    Nov 3, 2022

    Osteopenia, Osteoporosis Trial (Denosumab)

    Completed
    • Osteopenia
    • Osteoporosis
    • Denosumab
    • (no location specified)
    Nov 4, 2022

    Zoledronic Acid to Prevent Bone Loss Following Denosumab

    Recruiting
    • Osteoporosis
    • +3 more
    • Zoledronic acid
    • Calgary, Alberta, Canada
      University of Calgary, McCaig Institute for Bone and Joint Healt
    Nov 1, 2022

    Osteoporosis, Osteopenia, Early Postmenopause Trial in Erlangen (physical exercise)

    Active, not recruiting
    • Osteoporosis
    • +2 more
    • physical exercise
    • Erlangen, Bavaria, Germany
      Institute of Medical Physics, University of Erlangen-Nurnberg
    Nov 2, 2022

    Osteopenia Trial in Albuquerque (CBD, Placebo)

    Terminated
    • Osteopenia
    • Albuquerque, New Mexico
      NM Clinical Research & Osteoporosis Center, Inc.
    Sep 22, 2022

    Osteoporosis, Osteopenia Trial in Waterloo (Supervised strength training (group 1), Supervised strength training (group 2), Home

    Recruiting
    • Osteoporosis
    • Osteopenia
    • Supervised strength training (group 1)
    • +2 more
    • Waterloo, Ontario, Canada
      University of Waterloo
    Sep 12, 2022

    Hypogonadism, Osteopenia, Osteoporosis Trial in Boston (Testosterone, Alendronate, Placebo Alendronate)

    Terminated
    • Hypogonadism
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Aug 16, 2022

    Meniere Disease, Osteoporosis, Osteopenia Trial (vitamin D plasma levels baseline, Dual-energy X-ray absorptiometry at baseline,

    Not yet recruiting
    • Meniere Disease
    • +4 more
    • vitamin D plasma levels baseline
    • +17 more
    • (no location specified)
    Aug 2, 2022

    Osteopenia, Postmenopausal Osteopenia Trial in Kifissia (Calcium and vitamin D supplement, Calcium, vitamin D and prebiotic

    Recruiting
    • Osteopenia
    • Postmenopausal Osteopenia
    • Calcium and vitamin D supplement
    • +2 more
    • Kifissia, Athens, Greece
      Laboratory for Research of the Musculoskeletal System
    Jul 27, 2022

    Osteopenia Trial (Calcium from fish bone, Calcium carbonate)

    Not yet recruiting
    • Osteopenia
    • Calcium from fish bone
    • Calcium carbonate
    • (no location specified)
    May 18, 2022

    Osteopenia Trial in Omaha (Spry Belt)

    Active, not recruiting
    • Osteopenia
    • Spry Belt
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Apr 4, 2022

    Osteopenia Trial in Pittsburgh (Melatonin 5 mg, Osteogenic loading, Mock for Osteogenic Loading)

    Recruiting
    • Osteopenia
    • Melatonin 5 mg
    • +3 more
    • Pittsburgh, Pennsylvania
    • +1 more
    Mar 21, 2022

    Metabolic Bone Disease, Osteopenia, Neonatal Rickets Trial in Rochester (Vibro-acoustic analysis (VAA), based on ultrasound

    Enrolling by invitation
    • Metabolic Bone Disease
    • +2 more
    • Vibro-acoustic analysis (VAA), based on ultrasound radiation force
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Feb 9, 2022

    Sarcopenia, Osteopenia Trial in Boston (Anamorelin Hydrochloride, Placebo)

    Active, not recruiting
    • Sarcopenia
    • Osteopenia
    • Anamorelin Hydrochloride
    • Placebo
    • Boston, Massachusetts
      Jean Mayer USDA Human Nutrition Research Center on Aging at Tuft
    Feb 4, 2022